$104.72 +2.51 (%) Gilead Sciences Inc - NASDAQ

Oct. 21, 2014 | 12:56 PM

Partner Headlines

  1. Alexion: Keeping Up The Suspense Ahead Of Q3 Earnings

    IBD | Oct. 20, 2014 | 18:01PM EST
  2. Perrigo CEO Constructs "Five Pillars" For Success

    IBD | Oct. 17, 2014 | 17:03PM EST
  3. Stocks Up Big Friday, Recover Early Week Losses

    IBD | Oct. 17, 2014 | 16:24PM EST
  4. Barclays: Johnson & Johnson's Q3 Could Be 'High Water Mark'

    Benzinga | Oct. 15, 2014 | 16:42PM EST
  5. J&J raises outlook on Q3 beat

    IBD | Oct. 14, 2014 | 18:51PM EST
  6. Gilead

    IBD | Oct. 14, 2014 | 18:49PM EST
  7. Wall Street Ends Mixed; Airlines Soar As Oil Plunges

    IBD | Oct. 14, 2014 | 17:09PM EST
  8. Stocks Close Mixed, Surrendering Some Early Gains

    IBD | Oct. 14, 2014 | 16:23PM EST
  9. Stocks Retain Gains As Market Finally Gets A Rally

    IBD | Oct. 14, 2014 | 14:55PM EST
  10. Deutsche Bank Says Gilead Sciences Stock Reaction Is Overdone

    Benzinga | Oct. 14, 2014 | 13:59PM EST
  11. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD | Oct. 14, 2014 | 13:10PM EST
  12. J&J Earnings Beat; Olysio Chatter Hits Gilead

    IBD | Oct. 14, 2014 | 11:54AM EST
  13. JPM Posts Mixed 3Q as Trading Rebounds

    FoxBusiness | Oct. 14, 2014 | 09:40AM EST
  14. IBD 50: Medical, Internet Companies Top Q3 Estimates

    IBD | Oct. 13, 2014 | 19:15PM EST
  15. Apple, McKesson Among Big Caps In Trading Range

    IBD | Oct. 13, 2014 | 18:38PM EST
  16. Video: Intel Among Top 4 Earnings Reports Tuesday

    IBD | Oct. 13, 2014 | 16:26PM EST
  17. Big Swings in Biotech Short Interest

    Benzinga | Oct. 13, 2014 | 08:32AM EST
  18. New Gilead Hep-C Drug OK'd

    IBD | Oct. 10, 2014 | 19:03PM EST
  19. IBD 50: Medical, Internet Companies Top Q3 Profit Estimates

    IBD | Oct. 10, 2014 | 18:45PM EST
  20. Most Top Industry Groups Fall Harder Than Market

    IBD | Oct. 10, 2014 | 17:58PM EST
  21. Gilead's Hep C Combo Pill Harvoni Approved, Priced

    IBD | Oct. 10, 2014 | 15:13PM EST
  22. Release Confirms Gilead's Approval For Combination Hep C Product

    Benzinga | Oct. 10, 2014 | 13:56PM EST
  23. Weekly Review List Gets Smaller As Market Slumps

    IBD | Oct. 9, 2014 | 18:26PM EST
  24. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 9, 2014 | 18:00PM EST
  25. Indexes Slammed As Oil Prices, Stocks Sink

    IBD | Oct. 9, 2014 | 17:05PM EST
  26. Video: 3 Big Cap Biotechs Bucking Market Correction

    IBD | Oct. 8, 2014 | 17:49PM EST
  27. Three Leading Medicals Staying Healthy In Correction

    IBD | Oct. 8, 2014 | 16:36PM EST
  28. Merck, Bristol, Arrowhead Prep Hepatitis Studies

    IBD | Oct. 8, 2014 | 13:36PM EST
  29. Earnings Kickoff: What to Expect from 3Q Results

    FoxBusiness | Oct. 8, 2014 | 09:03AM EST
  30. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  31. Video: 5 Upcoming Earnings Reports To Watch

    IBD | Oct. 7, 2014 | 13:59PM EST
  32. Bristol-Myers Pulls FDA Filing For 2-Drug Hep C Combo

    IBD | Oct. 7, 2014 | 11:13AM EST
  33. Solid Q3 Earnings Predicted

    IBD | Oct. 6, 2014 | 18:53PM EST
  34. Wall St. Expects Solid Q3 Profit Despite Global Blues

    IBD | Oct. 6, 2014 | 17:46PM EST
  35. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD | Oct. 4, 2014 | 08:02AM EST
  36. Medical Stocks End Week On High Note, Biotechs Lead

    IBD | Oct. 4, 2014 | 08:02AM EST
  37. Second Oldest Stock Fund Is As Nimble As A Teenager

    IBD | Oct. 2, 2014 | 18:25PM EST
  38. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD | Oct. 2, 2014 | 18:25PM EST
  39. Will Gilead Sciences Score Healthy Gains For Investors?

    IBD | Oct. 2, 2014 | 13:03PM EST
  40. #PreMarket Primer: Wednesday, October 1: First Case Of Ebola In The US Confirmed

    Benzinga | Oct. 1, 2014 | 07:42AM EST
  41. J&J Moves Into Gilead's Turf

    IBD | Sep. 30, 2014 | 18:43PM EST
  42. J&J Buying Alios, Going Up Against Gilead

    IBD | Sep. 30, 2014 | 12:02PM EST
  43. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD | Sep. 29, 2014 | 18:32PM EST
  44. Gilead Sciences, Inc. Consolidating Gains?

    Benzinga | Sep. 29, 2014 | 15:30PM EST
  45. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts | Sep. 29, 2014 | 08:15AM EST
  46. Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26

    Benzinga | Sep. 27, 2014 | 10:33AM EST
  47. Many IBD 50 Stocks Testing Key Support Level

    IBD | Sep. 26, 2014 | 19:09PM EST
  48. There's More to Gilead Sciences than a Successful Drug

    GuruFocus | Sep. 26, 2014 | 19:07PM EST
  49. IBD 50: Gilead's Sovaldi Drives Earnings Growth

    IBD | Sep. 26, 2014 | 19:03PM EST
  50. Can Gilead Sciences Be A Do-Gooder And Still Do Well?

    IBD | Sep. 26, 2014 | 14:37PM EST
Trading Center